ARCA biopharma, Inc.
(NASDAQ : ABIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading ABIO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-3.48%80.471.8%$677.67m
BIIBBiogen Inc.
-4.02%229.021.0%$525.14m
CELGCelgene Corporation
-4.34%96.291.2%$438.11m
AMGNAmgen Inc.
-3.82%146.451.0%$388.51m
ANACAnacor Pharmaceuticals, Inc.
-0.14%99.0615.2%$320.35m
REGNRegeneron Pharmaceuticals, Inc.
-4.95%339.483.1%$301.85m
ALXNAlexion Pharmaceuticals, Inc.
-8.56%112.992.5%$274.13m
ILMNIllumina, Inc.
-5.24%138.914.9%$155.27m
VRTXVertex Pharmaceuticals Incorporated
-7.14%81.902.6%$124.14m
MDVNMedivation, Inc.
-3.90%56.952.8%$120.74m
BMRNBioMarin Pharmaceutical Inc.
-7.94%77.014.0%$117.35m
SRPTSarepta Therapeutics, Inc.
3.58%18.5249.4%$116.18m
CPXXCelator Pharmaceuticals, Inc.
0.13%30.198.5%$107.30m
AAgilent Technologies, Inc.
-5.48%44.121.0%$94.74m
IONSIonis Pharmaceuticals, Inc.
-6.91%21.978.6%$94.46m

Company Profile

ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company's business combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. ARCA biopharma was founded in 1992 and is headquartered in Westminster, CO.